These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7359368)

  • 1. Phenytoin-induced changes in quinidine and 3-hydroxyquinidine pharmacokinetics in conscious dogs.
    Jaillon P; Kates RE
    J Pharmacol Exp Ther; 1980 Apr; 213(1):33-7. PubMed ID: 7359368
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of the pharmacokinetics of quinidine.
    Neff CA; Davis LE; Baggot JD
    Am J Vet Res; 1972 Jul; 33(7):1521-5. PubMed ID: 5039523
    [No Abstract]   [Full Text] [Related]  

  • 3. Quinidine-rifampin interaction.
    Twum-Barima Y; Carruthers SG
    N Engl J Med; 1981 Jun; 304(24):1466-9. PubMed ID: 7231477
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs.
    Kuroha M; Shirai Y; Shimoda M
    J Vet Pharmacol Ther; 2004 Oct; 27(5):355-9. PubMed ID: 15500574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amiodarone on the pharmacokinetics of phenytoin, quinidine, and lidocaine in the rat.
    Fruncillo RJ; Kozin SH; DiGregorio GJ
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):451-4. PubMed ID: 4081327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.
    Greenblatt DJ; Pfeifer HJ; Ochs HR; Franke K; MacLaughlin DS; Smith TW; Koch-Weser J
    J Pharmacol Exp Ther; 1977 Aug; 202(2):365-78. PubMed ID: 577934
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetics of quinidine following the administration of a single intravenous dose or single and repeated oral doses in human subjects].
    Leucuţa SE; Zdrenghea D; Poruţiu D; Stăncioiu N
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(3):253-8. PubMed ID: 2891173
    [No Abstract]   [Full Text] [Related]  

  • 8. Digoxin alters quinidine and quinidine alters digoxin pharmacokinetics in dogs.
    Gibson TP; Nelson HA
    J Lab Clin Med; 1980 Mar; 95(3):417-28. PubMed ID: 7354243
    [No Abstract]   [Full Text] [Related]  

  • 9. [Development of serum and tissue concentrations of quinidine following intravenous injection].
    Armand J; Evreux JC; Badinand A; Faucon G
    Med Exp Int J Exp Med; 1969; 19(1):22-7. PubMed ID: 5395539
    [No Abstract]   [Full Text] [Related]  

  • 10. Reverse-phase liquid chromatography and pharmacokinetic study of two hydroxylated analogues of quinidine in dogs.
    Leroyer R; Jarreau C; Pays M; Varoquaux O; Advenier C
    J Pharm Sci; 1984 Jun; 73(6):844-6. PubMed ID: 6547483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of inhibitory effects of several fluoroquinolones on cytochrome P-450 3A activities at clinical dosage in dogs.
    Regmi NL; Abd El-Aty AM; Kubota R; Shah SS; Shimoda M
    J Vet Pharmacol Ther; 2007 Feb; 30(1):37-42. PubMed ID: 17217399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of a micromethod for sampling and for the specific quantitative evaluation of quinidine. I. Pharmacokinetic study after intravenous administration in the rat (author's transl)].
    Koskas JP; Sado PA; Devissaguet JP; Le Verge R
    J Pharm Belg; 1981; 36(3):187-92. PubMed ID: 7264865
    [No Abstract]   [Full Text] [Related]  

  • 13. Short- and long-acting oral quinidine preparations: clinical implications of pharmacokinetic differences.
    Woo E; Greenblatt DJ; Ochs HR
    Angiology; 1978 Mar; 29(3):243-50. PubMed ID: 646185
    [No Abstract]   [Full Text] [Related]  

  • 14. Noninteraction of digitoxin and quinidine.
    Ochs HR; Pabst J; Greenblatt DJ; Dengler HJ
    N Engl J Med; 1980 Sep; 303(12):672-4. PubMed ID: 7402253
    [No Abstract]   [Full Text] [Related]  

  • 15. An HPLC method for the quantitation of quinidine and its metabolites in plasma: an application to a quinidine-phenytoin drug interaction study.
    Pershing LK; Peat MA; Finkle BS
    J Anal Toxicol; 1982; 6(3):153-6. PubMed ID: 7109560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidine.
    Edwards DJ; Lavoie R; Beckman H; Blevins R; Rubenfire M
    Clin Pharmacol Ther; 1987 Jan; 41(1):68-73. PubMed ID: 3802708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualization of dosage of antiarrhythmic drugs.
    Kessler KM
    Med Clin North Am; 1974 Sep; 58(5):1019-26. PubMed ID: 4609363
    [No Abstract]   [Full Text] [Related]  

  • 18. Diphenylhydantoin.
    Glazko AJ
    Pharmacology; 1972; 8(1):163-77. PubMed ID: 4630160
    [No Abstract]   [Full Text] [Related]  

  • 19. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
    Wooding-Scott RA; Visco J; Slaughter RL
    Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age.
    Drayer DE; Hughes M; Lorenzo B; Reidenberg MM
    Clin Pharmacol Ther; 1980 Jan; 27(1):72-5. PubMed ID: 7351119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.